| Eli Lilly And Company | 11,684 | US$14M | 12.5% |
| Johnson & Johnson | 29,313 | US$7.44M | 6.6% |
| Merck & Company, Inc. | 57,698 | US$7.41M | 6.6% |
| Unitedhealth Group Incorporated | 12,747 | US$5.3M | 4.7% |
| Abbvie Inc. | 15,306 | US$3.85M | 3.4% |
| Intuitive Surgical, Inc. | 8,447 | US$3.36M | 3.0% |
| Elevance Health, Inc. | 8,597 | US$3.32M | 3.0% |
| Cvs Health Corporation | 31,846 | US$3.29M | 2.9% |
| Vertex Pharmaceuticals Incorporated | 6,088 | US$3.02M | 2.7% |
| Danaher Corporation | 15,625 | US$2.98M | 2.6% |
| Edwards Lifesciences Corporation | 30,064 | US$2.72M | 2.4% |
| Abbott Laboratories | 25,958 | US$2.36M | 2.1% |
| Cencora, Inc. | 8,209 | US$2.32M | 2.1% |
| Cardinal Health, Inc. | 8,573 | US$2.04M | 1.8% |
| Thermo Fisher Scientific Inc | 3,678 | US$1.84M | 1.6% |
| Hca Healthcare, Inc. | 4,608 | US$1.8M | 1.6% |
| Regeneron Pharmaceuticals, Inc. | 2,742 | US$1.71M | 1.5% |
| Biogen Inc. | 7,312 | US$1.58M | 1.4% |
| Agilent Technologies, Inc. | 11,491 | US$1.53M | 1.4% |
| Gsk Plc | 51,586 | US$1.35M | 1.2% |
| Boston Scientific Corporation | 31,220 | US$1.33M | 1.2% |
| Stryker Corporation | 4,189 | US$1.32M | 1.2% |
| Centene Corporation | 20,353 | US$1.31M | 1.2% |
| Medtronic Plc. | 14,617 | US$1.14M | 1.0% |
| United Therapeutics Corporation | 1,984 | US$1.07M | 0.96% |
| Incyte Corporation | 9,271 | US$1.05M | 0.94% |
| Dexcom, Inc. | 15,255 | US$1.03M | 0.91% |
| Argenx Se | 1,011 | US$938K | 0.83% |
| Ucb S.a. | 2,992 | US$896K | 0.80% |
| Ionis Pharmaceuticals, Inc. | 11,237 | US$891K | 0.79% |
| Steris Plc (ireland) | 4,043 | US$851K | 0.76% |
| Ascendis Pharma A/s | 3,191 | US$851K | 0.76% |
| Madrigal Pharmaceuticals, Inc. | 1,541 | US$827K | 0.74% |
| Cytokinetics, Incorporated | 9,655 | US$823K | 0.73% |
| Ptc Therapeutics, Inc. | 9,817 | US$801K | 0.71% |
| Alnylam Pharmaceuticals, Inc. | 2,629 | US$791K | 0.70% |
| Revolution Medicines, Inc. | 4,177 | US$782K | 0.70% |
| Elanco Animal Health Incorporated | 31,004 | US$763K | 0.68% |
| Bristol-myers Squibb Company | 12,812 | US$738K | 0.66% |
| Protagonist Therapeutics, Inc. | 5,818 | US$713K | 0.63% |
| Arcus Biosciences, Inc. | 22,493 | US$693K | 0.62% |
| Astrazeneca Plc | 3,643 | US$691K | 0.61% |
| Galderma Group Ag | 2,916 | US$663K | 0.59% |
| Dianthus Therapeutics, Inc. | 6,614 | US$645K | 0.57% |
| Kymera Therapeutics, Inc. | 5,448 | US$625K | 0.56% |
| Amgen Inc. | 1,716 | US$621K | 0.55% |
| Bridgebio Pharma, Inc. | 8,299 | US$618K | 0.55% |
| Pharvaris N.v. | 17,554 | US$607K | 0.54% |
| Encompass Health Corporation | 5,857 | US$592K | 0.53% |
| Disc Medicine, Inc. | 7,887 | US$577K | 0.51% |
| Icon Plc | 3,282 | US$570K | 0.51% |
| Adaptive Biotechnologies Corporation | 25,570 | US$548K | 0.49% |
| Scholar Rock Holding Corporation | 9,781 | US$538K | 0.48% |
| Heartflow, Inc. | 17,989 | US$528K | 0.47% |
| Mirum Pharmaceuticals, Inc. | 4,437 | US$519K | 0.46% |
| Alignment Healthcare, Inc. | 21,135 | US$503K | 0.45% |
| Option Care Health, Inc. | 23,096 | US$484K | 0.43% |
| Vaxcyte, Inc. | 8,272 | US$481K | 0.43% |
| Celldex Therapeutics, Inc. | 12,896 | US$480K | 0.43% |
| Qiagen N.v. | 11,870 | US$464K | 0.41% |
| Kailera Therapeutics, Inc. | 19,352 | US$426K | 0.38% |
| Cg Oncology, Inc. | 5,942 | US$422K | 0.38% |
| Trevi Therapeutics, Inc. | 21,888 | US$408K | 0.36% |
| Acadia Healthcare Company, Inc. | 13,029 | US$385K | 0.34% |
| Stoke Therapeutics, Inc. | 10,840 | US$355K | 0.32% |
| Immunome, Inc. | 16,589 | US$352K | 0.31% |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A | 43,876 | US$338K | 0.30% |
| Definium Therapeutics, Inc. | 7,100 | US$334K | 0.30% |
| Inspire Medical Systems, Inc. | 7,432 | US$332K | 0.30% |
| Genfleet Therapeutics (shanghai), Inc. Class H | 83,000 | US$314K | 0.28% |
| Crinetics Pharmaceuticals, Inc. | 6,881 | US$257K | 0.23% |
| Avalyn Pharma Inc. | 2,500 | US$82,300 | 0.07% |
| Alebund Pharmaceuticals (jiangsu) Limited Class H | 12,300 | US$72,017 | 0.06% |
| Alamar Biosciences, Inc. | 1,300 | US$35,217 | 0.03% |
| Apellis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Corvus Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Aktis Oncology, Inc. | 0 | US$0 | 0.00% |
| Natera, Inc. | 0 | US$0 | 0.00% |
| Eikon Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Avantor, Inc. | 0 | US$0 | 0.00% |
| Mineralys Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Oculis Holding Ag | 0 | US$0 | 0.00% |
| Newamsterdam Pharma Company N.v. | 0 | US$0 | 0.00% |
| Viridian Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Xenon Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Nuvalent, Inc. | 0 | US$0 | 0.00% |
| Bio-techne Corp | 0 | US$0 | 0.00% |